I recently provided insight about the potential shift in healthcare fraud oversight amid federal changes and several recent cases that could narrow the scope of investigations and ultimately lower costs that health systems spend to fight fraud allegations.
“Whether decreasing the cost of fraud investigations is a result of the Loper Bright decision, the [whistleblower] case or enforcement priorities of the Trump administration is unknown, but that is the direction things are heading,” I explained for Modern Healthcare.
The full article, “Why Hospitals Could See Lower Fraud Litigation Costs,” was published by Modern Healthcare on March 28 and is available online (subscription required).